Share price: 102.00p

Block Listing Update

14th December 2018

Further to the announcement by the Company on 5 June 2018, the Company announces that a total of 51,988 new ordinary shares of 10p each in the share capital of the Company (“Ordinary Shares”) have been issued and allotted since that date pursuant to the Company’s PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010 and admitted to trading in accordance with the block listing applied for at that time (the “Block Listing”). An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.

Enquires

Cello Health

020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Finance Director

Cenkos Securities

  020 7397 8900

Mark Connelly
Harry Hargreaves

BLOCK LISTING SIX MONTHLY RETURN

Name of applicant:

Cello Health plc

Name of scheme:

PSP Option Scheme 2010, Approved Share Option Plan 2009 and Unapproved Scheme 2010

Period of return:

From:

31 May 2018

To:

31 November 2018

Balance of unallotted securities under scheme(s) from previous return:

663,596

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(51,988)

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

611,608

Name of contact:

Mark Bentley, Group Finance Director

Telephone number of contact:

020 7812 8460

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150